Laminin matrix promotes hepatogenic terminal differentiation of human bone marrow mesenchymal stem cells

Khalaj, Zahra; Lotfi, Abbas Sahebghadam; Kabir-Salmani, Maryam
January 2016
Iranian Journal of Basic Medical Sciences;Jan2016, Vol. 19 Issue 1, p34
Academic Journal
Objective(s): The application of stem cells holds great promises in cell transplants. Considering the lack of optimal in vitro model for hepatogenic differentiation, this study was designed to examine the effects of laminin matrix on the improvement of in vitro differentiation of human bone marrow mesenchymal stem cells (hBM-MSC) into the more functional hepatocyte-like cells. Materials and Methods: Characterization of the hBM-MSCs was performed by immunophenotyping and their differentiation into the mesenchymal-derived lineage. Then, cells were seeded on the laminin-coated or tissue culture polystyrene (TCPS). The differentiation was carried out during two steps. Afterward, the expression of hepatocyte markers such as AFP, ALB, CK-18, and CK-19 as well as the expression of C-MET, the secretion of urea, and the activity of CYP3A4 enzyme were determined. Moreover, the cytoplasmic glycogen storage was examined by periodic acid-Schiff (PAS) staining. Results: The results demonstrated that the culture of hBM-MSC on laminin considerably improved hepatogenic differentiation compared to TCP group. A significant elevated level of urea biosynthesis and CYP3A4 enzyme activity was observed in the media of the laminin-coated differentiated cells (P<0.05). Furthermore higher expressions of both AFP and ALB were determined in cells differentiated on laminin matrix. Glycogen accumulation was not detected in the undifferentiated hBM-MSCs, however, both differentiated cells in laminin and TCPS groups demonstrated the intracellular glycogen accumulation on day 21 of hepatogenic differentiation. Conclusion: Taken together, these findings may indicate that laminin matrix can improve terminal differentiation of hepatocyte-like cells from hBM-MSCs. Thus, laminin might be considered as a suitable coating in hepatic tissue engineering designs.


Related Articles

  • Cell Mix Frees Transplantees From Immunosuppressive Drugs. Breindl, Anette // BioWorld Today;3/12/2012, Vol. 23 Issue 48, p1 

    The article discusses research on the use of bone marrow stem cells and facilitating cells to withdraw immunosuppressive drugs in kidney transplant recipients. It references a study by Ildstad and colleagues, published in the March 8, 2012 issue of "Science Translational Medicine." The study...

  • In vitro gene and chromosome characterization of expanded bone marrow mesenchymal stem cells for musculo-skeletal applications. ROSETI, L.; SERRA, M.; CANELLA, E.; MUNNO, C.; TOSI, A.; ZUNTINI, M.; PANDOLFI, M.; SANGIORGI, L.; BISO, R.; PITTALIS, M. C.; BINI, C.; PELOTTI, S.; GASBARRINI, A.; BORIANI, L.; BASSI, A.; GRIGOLO, B. // European Review for Medical & Pharmacological Sciences;Dec2014, Vol. 18 Issue 23, p3702 

    OBJECTIVE: A number of studies have shown the role of expanded Bone Marrow-derived Mesenchymal Stem Cells in the repair and regeneration of musculo-skeletal tissues. The current European regulations define in vitro expanded cells for clinical purposes as substantially manipulated and include...

  • Cytogenetic Effects of Heptaplatin on SWR/J Mouse Bone Marrow Cells. Al-Anazi, Khalid M. // Pakistan Journal of Zoology;Aug2015, Vol. 47 Issue 4, p1083 

    In the present study, the cytogenetic effects of the platinum based anti-tumour drug heptaplatin were analysed by measuring chromosomal aberrations and the mitotic index, in bone marrow cells of SWR/J mice. A single 5, 10 or 12.5 mg/kg body weight (b.wt) intraperitoneal dose of heptaplatin was...

  • Immunomodulatory Activity of Mesenchymal Stem Cells. Kaplan, Johanne M.; Youd, Michele E.; Lodie, Tracey A. // Current Stem Cell Research & Therapy;Dec2011, Vol. 6 Issue 4, p297 

    Mesenchymal stem cells (MSCs) were discovered as a rare population of non-hematopoietic stem cells that reside in the bone marrow and interact closely with hematopoietic stem cells to support their growth and differentiation. MSCs are multipotent cells that have the ability to differentiate into...

  • Dynamic microRNA Profiles of Hepatic Differentiated Human Umbilical Cord Lining-Derived Mesenchymal Stem Cells. Lina Cui; Xinmin Zhou; Jinge Li; Liuyi Wang; Jingbo Wang; Qiang Li; Jindong Chu; Linhua Zheng; Qiong Wu; Zheyi Han; Yongquan Shi; Ying Han; Daiming Fan; Rameshwar, Pranela // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    Despite the extensive hepatic differentiation potential of human umbilical cord lining-derived mesenchymal stem cells (hUC-MSC), little is known about the molecular mechanisms of hUC-MSC differentiation. At the post-transcriptional level, microRNAs are key players in the control of cell fate...

  • Autologous Bone Marrow Stem Cells combined with Allograft Cancellous Bone in Treatment of Nonunion. Thua, Trung Hau Le; Bui, Duc Phu; Nguyen, Duy Thang; Pham, Dang Nhat; Le, Quy Bao; Nguyen, Phan Huy; Tran, Ngoc Vu; Le, Phuoc Quang; Boeckx, Willy D.; Mey, Albert // Biomedical Research & Therapy;Dec2015, Vol. 2 Issue 12, p1 

    Autologous cancellous bone graft is currently used as a gold standard method for treatment of bone nonunion. However, there is a limit to the amount of autologous cancellous bone that can be harvested and the donor site morbidity presents a major disadvantage to autologous bone grafting....

  • Myogenic Potential of Whole Bone Marrow Mesenchymal Stem Cells In Vitro and In Vivo for Usage in Urinary Incontinence. Gunetti, Monica; Tomasi, Simone; Giammò, Alessandro; Boido, Marina; Rustichelli, Deborah; Mareschi, Katia; Errichiello, Edoardo; Parola, Maurizio; Ferrero, Ivana; Fagioli, Franca; Vercelli, Alessandro; Carone, Roberto; Câmara, Niels Olsen Saraiva // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    Urinary incontinence, defined as the complaint of any involuntary loss of urine, is a pathological condition, which affects 30% females and 15% males over 60, often following a progressive decrease of rhabdosphincter cells due to increasing age or secondary to damage to the pelvic floor...

  • Epidermal growth factor regulates hematopoietic regeneration after radiation injury. Doan, Phuong L; Himburg, Heather A; Helms, Katherine; Russell, J Lauren; Fixsen, Emma; Quarmyne, Mamle; Harris, Jeffrey R; Deoliviera, Divino; Sullivan, Julie M; Chao, Nelson J; Kirsch, David G; Chute, John P // Nature Medicine;Mar2013, Vol. 19 Issue 3, p295 

    The mechanisms that regulate hematopoietic stem cell (HSC) regeneration after myelosuppressive injury are not well understood. We identified epidermal growth factor (EGF) to be highly enriched in the bone marrow serum of mice bearing deletion of Bak and Bax in TIE2-expressing cells in Tie2Cre;...

  • Further Proof for an Unpopular Concept: A Single Cell From Bone Marrow Can Serve as a Stem Cell for Both Hematopoiesis and Osteogenesis. Prockop, Darwin J // Molecular Therapy;Jun2013, Vol. 21 Issue 6, p1116 

    The article discusses research being done on the role of single cell from bone marrow in the long-term repopulating hematopoietic stem cell (LTR-HSC). The article references the study "Transplanted Murine Long-Term Repopulating Hematopoietic Cells Can Differentiate to Osteoblasts in the Marrow...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics